ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 6,090.00
+30.00 (0.50%)
At close: Mar 13, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 124.23 billion as of March 13, 2026. Its market cap has increased by 175.00% in one year.
Market Cap
124.23B
Enterprise Value
86.93B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,090.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 124.23B, a decrease of -77.87%. That is a compound annual growth rate of -28.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 124.23B | -37.85% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 122.47B |
| CORESTEMCHEMON | 117.55B |
| BIO-FD&C | 116.61B |
| NovMetaPharma | 114.16B |
| Progen | 102.24B |
| Quratis | 98.72B |
| TegoScience | 96.08B |
| Cell Biotech | 94.99B |